Short answer · Medically reviewed summary · Last updated: 2026-04-07
Usher syndrome is estimated to affect between 3 and 6 per 100,000 individuals globally, though these figures vary significantly by region and genetic subtype. While it is considered a rare disease, it remains the most common genetic cause of combined deafness and blindness, with true prevalence likely higher due to underdiagnosis and the late-onset nature of some clinical features. What is the estimated prevalence and incidence of Usher syndrome? Epidemiological data for Usher syndrome indicates a global prevalence of approximately 3 to 6 per 100,000 people.
2 people with Usher Syndrome have shared their first-person experience on this question at DiseaseMaps.
Usher syndrome is estimated to affect between 3 and 6 per 100,000 individuals globally, though these figures vary significantly by region and genetic subtype. While it is considered a rare disease, it remains the most common genetic cause of combined deafness and blindness, with true prevalence likely higher due to underdiagnosis and the late-onset nature of some clinical features.
Epidemiological data for Usher syndrome indicates a global prevalence of approximately 3 to 6 per 100,000 people. It is categorized as a rare disease. Because Usher syndrome is inherited in an autosomal recessive pattern, its incidence is heavily influenced by the carrier frequency of specific genetic mutations within a population. In most clinical studies, the incidence of Usher syndrome is estimated to be roughly 1 in 25,000 to 1 in 30,000 live births, though these numbers are approximations based on historical registries and may not capture undiagnosed cases in populations with limited genetic screening access.
Current medical literature suggests that Usher syndrome affects males and females with equal frequency, as the causative genes are primarily located on autosomal chromosomes rather than sex chromosomes. However, significant geographic and ethnic variations exist. For example, the prevalence of Usher syndrome type 1F is notably higher in the Ashkenazi Jewish population due to a founder effect. In other regions, such as parts of Scandinavia or specialized cohorts in North America, specific genetic subtypes may appear more frequently, illustrating how population genetics shape the distribution of Usher syndrome globally.
Accurate reporting of Usher syndrome is notoriously difficult for several clinical and diagnostic reasons:
While formal epidemiological studies provide a macro-level view, the DiseaseMaps.org community offers a vital, real-world perspective. Currently, 214 people with Usher syndrome have joined the DiseaseMaps.org community to share their lived experiences. This data is invaluable because it captures the patient journey—from initial diagnostic delays to the daily management of symptoms—that often remains invisible in traditional clinical statistics. By connecting individuals globally, this community helps bridge the gap between theoretical prevalence numbers and the lived reality of those navigating this rare condition.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.